1-3 of 3
Keywords: Neoadjuvant
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Sarcopenia as a Predictive Factor for Response to Upfront Cisplatin-Based Chemotherapy in Patients with Muscle-Invasive Urothelial Bladder Cancer

Available to Purchase
Subject Area:
Further Areas
Judith Stangl-Kremser, Andrea Mari, David D’Andrea, Shoji Kimura, Irene Resch, Shahrokh F. Shariat, Tobias Klatte
Journal: Urologia Internationalis
Urol Int (2018) 101 (2): 197–200.
https://doi.org/10.1159/000489013
Published Online: 08 August 2018
... and Treatment of Cancer Genito-Urinary Tract Cancer Group; Australian Bladder Cancer Study Group; National Cancer Institute of Canada Clinical Trials Group; Finnbladder, et al: International phase III trial assessing neoadjuvant cisplatin, methotrexate, and vinblastine chemotherapy for muscle-invasive bladder...
View articletitled, Sarcopenia as a Predictive Factor for Response to Upfront Cisplatin-Based Chemotherapy in Patients with Muscle-Invasive Urothelial Bladder Cancer
Open the PDF for Sarcopenia as a Predictive Factor for Response to Upfront Cisplatin-Based Chemotherapy in Patients with Muscle-Invasive Urothelial Bladder Cancer in another window
Journal Articles

Clinical Significance of Neoadjuvant Combined Androgen Blockade for More Than Six Months in Patients with Localized Prostate Cancer Treated with Prostate Brachytherapy

Available to Purchase
Subject Area:
Further Areas
Tomokazu Senzaki, Tomoharu Fukumori, Hidehisa Mori, Yoshito Kusuhara, Masatsugu Komori, Junichiro Kagawa, Tomoya Fukawa, Yasuyo Yamamoto, Kunihisa Yamaguchi, Masayuki Takahashi, Akiko Kubo, Takashi Kawanaka, Shunsuke Furutani, Hitoshi Ikushima, Hiro-omi Kanayama
Journal: Urologia Internationalis
Urol Int (2015) 95 (4): 457–464.
https://doi.org/10.1159/000439573
Published Online: 14 October 2015
... is to clarify the clinical significance of neoadjuvant combined androgen blockade (CAB) for ≥6 months in patients with localized prostate cancer. Patients and Methods: A total of 431 patients with localized prostate cancer who underwent prostate brachytherapy (BT) with or without neoadjuvant CAB for ≥6 months...
View articletitled, Clinical Significance of Neoadjuvant Combined Androgen Blockade for More Than Six Months in Patients with Localized Prostate Cancer Treated with Prostate Brachytherapy
Open the PDF for Clinical Significance of Neoadjuvant Combined Androgen Blockade for More Than Six Months in Patients with Localized Prostate Cancer Treated with Prostate Brachytherapy in another window
Journal Articles

Is the Post-Radical Prostatectomy Gleason Score a Valid Predictor of Mortality after Neoadjuvant Hormonal Treatment?

Available to Purchase
Subject Area:
Further Areas
Michael Froehner, Stefan Propping, Rainer Koch, Angelika Borkowetz, Dorothea Liebeheim, Marieta Toma, Gustavo B. Baretton, Manfred P. Wirth
Journal: Urologia Internationalis
Urol Int (2016) 96 (3): 302–308.
https://doi.org/10.1159/000440729
Published Online: 07 October 2015
...Michael Froehner; Stefan Propping; Rainer Koch; Angelika Borkowetz; Dorothea Liebeheim; Marieta Toma; Gustavo B. Baretton; Manfred P. Wirth Purpose: To evaluate the validity of the Gleason score after neoadjuvant hormonal treatment as predictor of disease-specific mortality after radical...
View articletitled, Is the Post-Radical Prostatectomy Gleason Score a Valid Predictor of Mortality after Neoadjuvant Hormonal Treatment?
Open the PDF for Is the Post-Radical Prostatectomy Gleason Score a Valid Predictor of Mortality after Neoadjuvant Hormonal Treatment? in another window